PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

The Funding Paradigm., page-12

  1. 871 Posts.
    lightbulb Created with Sketch. 216
    Nice post Mozz.
    Semantics but we would have to settle for second for HFpEF. SGLT2’s have been approved for this indication in recent years.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.